Evaluation of point-of-care testing (POCT) for blood-borne infections in forensic autopsy specimens
Open Access
- 11 November 2026
- journal article
- Published by American Society for Microbiology in Microbiology Spectrum
Abstract
Lateral flow immunoassay (LFIA)-based point-of-care testing (POCT) for viral antigen and antibody detection enables rapid screening for blood-borne viral infections and may be particularly valuable in forensic autopsy settings, where incomplete antemortem medical histories and invasive procedures increase the risk of occupational exposure. However, its performance in postmortem specimens remains unclear. We evaluated the applicability of LFIA-based POCT for detecting human immunodeficiency virus (HIV), hepatitis C virus (HCV), and hepatitis B virus (HBV) in autopsy specimens, focusing on postmortem decomposition and the use of solid organ tissues as alternatives to blood. A total of 309 cases were analyzed using LFIA and quantitative polymerase chain reaction (qPCR) across blood, liver, and spleen specimens. Agreement was assessed using overall, positive, and negative percent agreement and Cohen’s kappa coefficient ( κ ). Positivity rates were compared by specimen type and decomposition status. LFIA agreement with qPCR varied by marker and specimen type, with substantial agreement for HIV and HCV antibody detection in blood and lower agreement in liver and spleen. Fresh specimens generally demonstrated higher LFIA positivity rates than decomposed specimens. Among specimens meeting predefined qPCR positivity criteria, LFIA-positive specimens tended to exhibit higher viral loads than LFIA-negative specimens, reaching statistical significance for HBV in liver, with similar but non-significant trends for blood HBV and liver HCV. LFIA-based POCT may serve as a preliminary screening tool in postmortem settings, particularly when blood is available. Nevertheless, negative results do not exclude infection—especially with low viral loads or advanced decomposition—and should be confirmed by molecular testing. IMPORTANCE: Forensic personnel performing autopsies face significant occupational risks from exposure to blood-borne viruses, including human immunodeficiency virus, hepatitis B virus, and hepatitis C virus. Unlike clinical settings, forensic autopsies frequently involve bodies with unknown infection histories, making rapid infection screening essential for personnel safety. Lateral flow immunoassay (LFIA)-based point-of-care testing (POCT) for viral antigen and antibody detection offers a rapid, infrastructure-free screening option; however, its performance in postmortem specimens has not been systematically evaluated. This study suggests that rapid immunochromatographic POCT may serve as a preliminary screening tool in forensic autopsy settings, particularly when blood specimens are available. However, a negative result does not exclude infection, especially in cases with low viral load or advanced decomposition, and confirmatory molecular testing remains necessary. These findings provide practical guidance for forensic professionals on appropriate specimen selection and interpretation of LFIA results, ultimately supporting safer autopsy practices.Funding Information
- National Research Foundation of Korea (RS-2024-00355224)
This publication has 27 references indexed in Scilit:
- The global burden of HIVClinics in Dermatology, 2024
- HCV, HIV AND HBV rapid test diagnosis in non-clinical outreach settings can be as accurate as conventional laboratory testsScientific Reports, 2023
- Prevalence of blood-borne infections in forensic samples: Epidemiology in areas of Chiba, JapanJournal of Forensic and Legal Medicine, 2022
- Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling studyThe Lancet Gastroenterology & Hepatology, 2017
- HIV-1 cellular and tissue replication patterns in infected humanized miceScientific Reports, 2016
- Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013The Lancet, 2015
- Rapid HIV screening: Missed opportunities for HIV diagnosis and preventionJournal of Clinical Virology, 2012
- Hepatitis B virus quasispecies in hepatic and extrahepatic viral reservoirs in liver transplant recipients on prophylactic therapyLiver Transplantation, 2011
- Control of cccDNA function in hepatitis B virus infectionJournal of Hepatology, 2009
- Dynamics of Hepatitis C Virus Replication in Human LiverThe American Journal of Pathology, 2003